Determining the hospital cost of anterior epistaxis treatment modalities at a Canadian tertiary care centre

Objective: To estimate the hospital costs of managing anterior epistaxis in the Emergency Department at a Tertiary Care centre in Canada. Material and methods: A cost analysis was conducted based on a retrospective review of Emergency Department visits from January 2012 to May 2014. A consecutive sa...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Harrish Nithianandan, Kednapa Thavorn, Fatmahalzahra Banaz, Kristian Macdonald, Andrea Lasso, Shaun J. Kilty
Formato:	article
Lenguaje:	EN
Publicado:	KeAi Communications Co., Ltd. 2019
Materias:	Otorhinolaryngology RF1-547 Surgery RD1-811
Acceso en línea:	https://doaj.org/article/c278905b5dff48c58137646dd6bfc586
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c278905b5dff48c58137646dd6bfc586
record_format	dspace
spelling	oai:doaj.org-article:c278905b5dff48c58137646dd6bfc5862021-12-02T14:22:03ZDetermining the hospital cost of anterior epistaxis treatment modalities at a Canadian tertiary care centre2095-881110.1016/j.wjorl.2019.11.001https://doaj.org/article/c278905b5dff48c58137646dd6bfc5862019-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S209588111930126Xhttps://doaj.org/toc/2095-8811Objective: To estimate the hospital costs of managing anterior epistaxis in the Emergency Department at a Tertiary Care centre in Canada. Material and methods: A cost analysis was conducted based on a retrospective review of Emergency Department visits from January 2012 to May 2014. A consecutive sample of adult patients with a diagnosis of anterior epistaxis was included. Anterior epistaxis was managed via one of: Nasal clip, Merocel®, Silver Nitrate cautery, Vaseline packing, other treatment or no treatment. Both the direct and indirect hospital costs ($CDN) for anterior epistaxis treatment were calculated from the hospital's perspective. Generalized linear models were used to assess the association between treatment modalities and total hospital costs while controlling for potential confounding factors. Results: Three hundred and fifty-three patients (49% female) with a mean age of (69.9 ± 18.5) years were included in the analysis. The median (interquartile ranges) costs of treatment ranged from C$227.83 (C$167.96, C$328.69) for observation to C$763.98 (C$632.25,C$830.23) for Merocel®. The overall median total hospital costs incurred across all modalities was C$566.24 (C$459.61, C$753.46) for the management of anterior epistaxis. Silver Nitrate, nasal clip, and observation were statistically associated with a lower cost when compared to Merocel® (P < 0.001) even after potential confounding factors were controlled. Conclusions: Our results show wide difference in the hospital cost of epistaxis across treatment modalities. These cost estimates can help inform future economic evaluation studies aiming to guide the allocation of health care resources for patients with epistaxis. Keywords: Anterior epistaxis, Nasal packing, Cautery, Silver nitrate, Hospital costsHarrish NithianandanKednapa ThavornFatmahalzahra BanazKristian MacdonaldAndrea LassoShaun J. KiltyKeAi Communications Co., Ltd.articleOtorhinolaryngologyRF1-547SurgeryRD1-811ENWorld Journal of Otorhinolaryngology-Head and Neck Surgery, Vol 5, Iss 4, Pp 193-199 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Otorhinolaryngology RF1-547 Surgery RD1-811
spellingShingle	Otorhinolaryngology RF1-547 Surgery RD1-811 Harrish Nithianandan Kednapa Thavorn Fatmahalzahra Banaz Kristian Macdonald Andrea Lasso Shaun J. Kilty Determining the hospital cost of anterior epistaxis treatment modalities at a Canadian tertiary care centre
description	Objective: To estimate the hospital costs of managing anterior epistaxis in the Emergency Department at a Tertiary Care centre in Canada. Material and methods: A cost analysis was conducted based on a retrospective review of Emergency Department visits from January 2012 to May 2014. A consecutive sample of adult patients with a diagnosis of anterior epistaxis was included. Anterior epistaxis was managed via one of: Nasal clip, Merocel®, Silver Nitrate cautery, Vaseline packing, other treatment or no treatment. Both the direct and indirect hospital costs ($CDN) for anterior epistaxis treatment were calculated from the hospital's perspective. Generalized linear models were used to assess the association between treatment modalities and total hospital costs while controlling for potential confounding factors. Results: Three hundred and fifty-three patients (49% female) with a mean age of (69.9 ± 18.5) years were included in the analysis. The median (interquartile ranges) costs of treatment ranged from C$227.83 (C$167.96, C$328.69) for observation to C$763.98 (C$632.25,C$830.23) for Merocel®. The overall median total hospital costs incurred across all modalities was C$566.24 (C$459.61, C$753.46) for the management of anterior epistaxis. Silver Nitrate, nasal clip, and observation were statistically associated with a lower cost when compared to Merocel® (P < 0.001) even after potential confounding factors were controlled. Conclusions: Our results show wide difference in the hospital cost of epistaxis across treatment modalities. These cost estimates can help inform future economic evaluation studies aiming to guide the allocation of health care resources for patients with epistaxis. Keywords: Anterior epistaxis, Nasal packing, Cautery, Silver nitrate, Hospital costs
format	article
author	Harrish Nithianandan Kednapa Thavorn Fatmahalzahra Banaz Kristian Macdonald Andrea Lasso Shaun J. Kilty
author_facet	Harrish Nithianandan Kednapa Thavorn Fatmahalzahra Banaz Kristian Macdonald Andrea Lasso Shaun J. Kilty
author_sort	Harrish Nithianandan
title	Determining the hospital cost of anterior epistaxis treatment modalities at a Canadian tertiary care centre
title_short	Determining the hospital cost of anterior epistaxis treatment modalities at a Canadian tertiary care centre
title_full	Determining the hospital cost of anterior epistaxis treatment modalities at a Canadian tertiary care centre
title_fullStr	Determining the hospital cost of anterior epistaxis treatment modalities at a Canadian tertiary care centre
title_full_unstemmed	Determining the hospital cost of anterior epistaxis treatment modalities at a Canadian tertiary care centre
title_sort	determining the hospital cost of anterior epistaxis treatment modalities at a canadian tertiary care centre
publisher	KeAi Communications Co., Ltd.
publishDate	2019
url	https://doaj.org/article/c278905b5dff48c58137646dd6bfc586
work_keys_str_mv	AT harrishnithianandan determiningthehospitalcostofanteriorepistaxistreatmentmodalitiesatacanadiantertiarycarecentre AT kednapathavorn determiningthehospitalcostofanteriorepistaxistreatmentmodalitiesatacanadiantertiarycarecentre AT fatmahalzahrabanaz determiningthehospitalcostofanteriorepistaxistreatmentmodalitiesatacanadiantertiarycarecentre AT kristianmacdonald determiningthehospitalcostofanteriorepistaxistreatmentmodalitiesatacanadiantertiarycarecentre AT andrealasso determiningthehospitalcostofanteriorepistaxistreatmentmodalitiesatacanadiantertiarycarecentre AT shaunjkilty determiningthehospitalcostofanteriorepistaxistreatmentmodalitiesatacanadiantertiarycarecentre
_version_	1718391513420922880

Determining the hospital cost of anterior epistaxis treatment modalities at a Canadian tertiary care centre

Ejemplares similares